IDEAS home Printed from https://ideas.repec.org/h/spr/prochp/978-3-031-56576-2_15.html
   My bibliography  Save this book chapter

A Dolutegravir-Associated Hyperglycemia Computational Prediction Tool for People Living with HIV in Uganda

In: Artificial Intelligence Tools and Applications in Embedded and Mobile Systems

Author

Listed:
  • Ceaser Wisdom Favor

    (School of Computational and Communication Science and Engineering, Nelson Mandela African Institution of Science and Technology
    Infectious Disease Institute)

  • Sinde Ramadhan

    (School of Computational and Communication Science and Engineering, Nelson Mandela African Institution of Science and Technology)

  • Michael Kisangiri

    (School of Computational and Communication Science and Engineering, Nelson Mandela African Institution of Science and Technology)

  • Levicatus Mugenyi

    (The AIDS Support Organisation)

  • Francis Musinguzi

    (Infectious Disease Institute)

  • Martin Balaba

    (Infectious Disease Institute)

  • Noela Owarwo

    (Infectious Disease Institute)

  • Eva Laker

    (Infectious Disease Institute)

  • Ruth Obaikol

    (Infectious Disease Institute)

  • Agnes Kiraga

    (Infectious Disease Institute)

  • Barbara Castelnuovo

    (Infectious Disease Institute)

  • Rosalind Parkes-Ratanshi

    (Infectious Disease Institute
    University of Cambridge)

Abstract

Dolutegravir-based antiretroviral therapy (ART) is the recommended treatment for persons living with HIV (PLWH). While incidence and prevalence rates are unclear among PLWH, clinical research has shown that the use of Dolutegravir (DTG) results in momentous hyperglycemia. Identification of patients at risk of DTG-associated hyperglycemia prior to switching to DTG regimens would lower morbidity and mortality in this group. A machine learning (ML) prediction tool was developed and evaluated for this purpose. ML methods were used to process and model a longitudinal cohort secondary dataset of 9077 treatment-experienced participants. DTG-associated hyperglycemia risk factors were used as model features. The data was split into training and testing datasets in a ratio of 2:1. A total of 6807 records were used to train eight models. Among others, the study found the XG-Boost model with the best metrics of; 0.87 probability of classifying positives, 0.67 a precision to positives, 0.86 area under the precision-recall curve, 0.76 F1 score, and 0.72 Cohen Kappa. ML techniques can be harnessed to build DTG-associated hyperglycemia prediction tools for screening PLWH before being switched to DTG and avoid unintended hyperglycemia.

Suggested Citation

  • Ceaser Wisdom Favor & Sinde Ramadhan & Michael Kisangiri & Levicatus Mugenyi & Francis Musinguzi & Martin Balaba & Noela Owarwo & Eva Laker & Ruth Obaikol & Agnes Kiraga & Barbara Castelnuovo & Rosali, 2024. "A Dolutegravir-Associated Hyperglycemia Computational Prediction Tool for People Living with HIV in Uganda," Progress in IS, in: Jorge Marx Gómez & Anael Elikana Sam & Devotha Godfrey Nyambo (ed.), Artificial Intelligence Tools and Applications in Embedded and Mobile Systems, pages 165-181, Springer.
    • Handle: RePEc:spr:prochp:978-3-031-56576-2_15
    DOI: 10.1007/978-3-031-56576-2_15
    as

    Download full text from publisher

    To our knowledge, this item is not available for download. To find whether it is available, there are three options:
    1. Check below whether another version of this item is available online.
    2. Check on the provider's web page whether it is in fact available.
    3. Perform a search for a similarly titled item that would be available.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:prochp:978-3-031-56576-2_15. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.